Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Elife ; 112022 12 07.
Artículo en Inglés | MEDLINE | ID: mdl-36475543

RESUMEN

Recently published single-cell sequencing data from individual human sperm (n=41,189; 969-3377 cells from each of 25 donors) offer an opportunity to investigate questions of inheritance with improved statistical power, but require new methods tailored to these extremely low-coverage data (∼0.01× per cell). To this end, we developed a method, named rhapsodi, that leverages sparse gamete genotype data to phase the diploid genomes of the donor individuals, impute missing gamete genotypes, and discover meiotic recombination breakpoints, benchmarking its performance across a wide range of study designs. We then applied rhapsodi to the sperm sequencing data to investigate adherence to Mendel's Law of Segregation, which states that the offspring of a diploid, heterozygous parent will inherit either allele with equal probability. While the vast majority of loci adhere to this rule, research in model and non-model organisms has uncovered numerous exceptions whereby 'selfish' alleles are disproportionately transmitted to the next generation. Evidence of such 'transmission distortion' (TD) in humans remains equivocal in part because scans of human pedigrees have been under-powered to detect small effects. After applying rhapsodi to the sperm data and scanning for evidence of TD, our results exhibited close concordance with binomial expectations under balanced transmission. Together, our work demonstrates that rhapsodi can facilitate novel uses of inferred genotype data and meiotic recombination events, while offering a powerful quantitative framework for testing for TD in other cohorts and study systems.


Many species on Earth can carry up to two different versions of a given gene, with each of these 'alleles' having only a 50/50 chance of being transmitted to the next generation via sexual reproduction. Certain 'selfish' sequences, however, can hijack this process and increase their probability of being passed on to an offspring. Known as transmission distortion, this phenomenon may result in alleles spreading through the population even if they are detrimental to fertility. Transmission distortion has been detected in many species such as flies, mice and some plants. It can take place at various stages during reproduction; for example, the selfish alleles may become overrepresented among eggs or sperm. However, scientists need to study a large number of offspring or reproductive cells to be able to detect whether an allele is inherited more often than expected. This has made it difficult to determine whether transmission distortion also happens in humans, and research so far has resulted in conflicting conclusions. A recently published dataset of human sperm from 25 donors offered Carioscia, Weaver et al. the opportunity to examine this question. Every volunteer had produced between 969 and 3377 sperm cells, each with about 1% of their genome sequenced. Carioscia, Weaver et al. developed a computational method, which they named rhapsodi, that allowed them to 'fill in the gaps' and infer missing regions of the genome for each cell. To do so, they relied on the fact that sperm cells from a given individual are highly related to one another. With this more complete data at hand, it became possible to look for evidence of transmission distortion by searching for alleles that were overrepresented in sperm from a given donor. No selfish sequence could be detected in any of the 25 individuals, suggesting that human sperm may not be subject to pervasive transmission distortion. Signatures of selfish alleles detected in previous human studies may have therefore not resulted from this mechanism taking place at the sperm level. Instead, transmission distortion in humans could primarily target eggs or happen at later stages (for instance, if embryos carrying the selfish allele have better chances of survival). The 'rhapsodi' method developed by Carioscia, Weaver et al. should allow other scientists to work with datasets for which large portions of the genetic information is missing. It may therefore become easier for researchers to track selfish alleles which are difficult to detect, and to examine bigger, more diverse samples which also include individuals with known fertility challenges.


Asunto(s)
Células Germinativas , Semen , Humanos , Masculino , Genotipo , Espermatozoides , Heterocigoto , Alelos , Meiosis
2.
PLoS One ; 12(6): e0179376, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28632749

RESUMEN

Soil-transmitted helminths (STHs) are intestinal parasitic nematodes that infect humans, and are transmitted through contaminated soil. These nematodes include the large roundworm (Ascaris lumbricoides), whipworm (Trichuris trichiura), and hookworm (Ancylostoma ceylanicum, Ancylostoma duodenale, and Necator americanus). Nearly 1.5 billion people (~24% of the population) worldwide are infected with at least one species of these parasites, burdening the poor, in particular, children and pregnant women. To combat these diseases, the WHO only recognizes four anthelmintic drugs, including the preferred drug, albendazole, for mass drug administration (MDA). These four drugs have a total of two different mechanisms of action, and, as expected, resistance has been observed. This problem calls for new drugs with different mechanisms of action. Although there is precedence for the use of Caenorhabditis elegans (C. elegans), a free-living nematode, as a model for drug screening and anthelmintic testing, their usefulness for such anthelmintic study is not clear as past research has shown that C. elegans did not show a strong response to albendazole, the MDA drug of choice, in comparison with various STHs under similar treatment. To further examine if C. elegans has the potential to be a good model organism for anthelmintic drug study, we employed a health rating scale in order to tease out potential effects of albendazole, and other anthelmintics, that may have been missed using a binary, dead/alive scale. Using the health-rating scale we found that although the worms may have not been dying, they were sick, showing dose responses to anthelmintic drugs, including albendazole, reinforcing C. elegans as a useful model for anthelmintic study.


Asunto(s)
Antihelmínticos/farmacología , Caenorhabditis elegans/efectos de los fármacos , Albendazol/farmacología , Albendazol/uso terapéutico , Animales , Antihelmínticos/uso terapéutico , Helmintiasis/tratamiento farmacológico , Humanos , Concentración 50 Inhibidora , Ivermectina/farmacología , Ivermectina/uso terapéutico , Dosificación Letal Mediana , Nitrocompuestos , Pruebas de Sensibilidad Parasitaria , Pirantel/farmacología , Pirantel/uso terapéutico , Tiazoles/farmacología , Tiazoles/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA